factual
Cancer Drugs No Longer Need Comparator Arms
Cancer drug studies do not typically have a comparator arm anymore and do not need one to receive FDA approval for a novel therapeutic, which makes the advisory committee's heavy focus on blinding for MDMA surprising by comparison.
factualpending
Speaker
Jennifer MitchellEvidence Quote
“you don't need the comparator arm to receive fda approval for a novel therapeutic”
Created: 6/14/2026, 2:01:41 AM
Your notes
Loading notes...